Cancer drugs do not cost as much to produce as industry-sponsored research claims, according to a landmark analysis.
Pharmaceutical companies often say it costs $2.7billion to produce medication to fight cancer, though there is no public data to support that.
However, the new study published today in JAMA Internal Medicine concludes it costs around $650million – less than a quarter of the commonly-cited figure.
The researchers at Oregon Health and Science University and Memorial Sloan Kettering say the findings suggest the industry’s prices may be wildly extortionate.
